Telatinib Uses, Dosage, Side Effects and more
Telatinib is under investigation in clinical trial NCT03817411 (Telatinib in Combination With Capecitabine/ Oxaliplatin in 1st Line Gastric or GEJ Cancer).
| Trade Name | Telatinib |
| Generic | Telatinib |
| Telatinib Other Names | Telatinib |
| Type | |
| Formula | C20H16ClN5O3 |
| Weight | Average: 409.83 Monoisotopic: 409.0941671 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
